Second-trimester amniotic fluid proteins changes in subsequent spontaneous preterm birth.
Pregnancy
Infant, Newborn
Female
Humans
Male
Premature Birth
/ metabolism
Amniotic Fluid
/ metabolism
Pregnancy Trimester, Second
Tumor Necrosis Factor-alpha
/ metabolism
Osteopontin
/ metabolism
Interleukin-33
/ metabolism
Interleukin-6
/ metabolism
Procollagen
/ metabolism
Amniocentesis
Cytokines
/ metabolism
Transforming Growth Factor beta
/ metabolism
Mycoplasma hominis
Ureaplasma urealiticum
IL-33
amniotic fluid
osteopontin
preterm birth
procollagen
second-trimester pregnancy
Journal
Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
revised:
10
01
2023
received:
16
10
2022
accepted:
14
02
2023
medline:
6
4
2023
pubmed:
15
3
2023
entrez:
14
3
2023
Statut:
ppublish
Résumé
The global sequence of the pathogenesis of preterm labor remains unclear. This study aimed to compare amniotic fluid concentrations of extracellular matrix-related proteins (procollagen, osteopontin and IL-33), and of cytokines (IL-19, IL-6, IL-20, TNFα, TGFβ, and IL-1β) in asymptomatic women with and without subsequent spontaneous preterm delivery. We used amniotic fluid samples of singleton pregnancy, collected by amniocentesis between 16 and 20 weeks' gestation, without stigmata of infection (i.e., all amniotic fluid samples were tested with broad-range 16 S rDNA PCR to distinguish samples with evidence of past bacterial infection from sterile ones), during a randomized, double-blind, placebo-controlled trial to perform a nested case-control laboratory study. Cases were women with a spontaneous delivery before 37 weeks of gestation (preterm group). Controls were women who gave birth at or after 39 weeks (full term group). Amniotic fluid concentrations of the extracellular matrix-related proteins and cytokines measured by immunoassays were compared for two study groups. gov: NCT00718705. Between July 2008 and July 2011, in 12 maternal-fetal medicine centers in France, 166 women with available PCR-negative amniotic fluid samples were retained for the analysis. Concentrations of procollagen, osteopontin, IL-19, IL-6, IL-20, IL-33, TNFα, TGFβ, and IL-1β were compared between the 37 who gave birth preterm and the 129 women with full-term delivery. Amniotic fluid levels of procollagen, osteopontin, IL-19, IL-33, and TNFα were significantly higher in the preterm than the full-term group. IL-6, IL-20, TGFβ, and IL-1β levels did not differ between the groups. In amniotic fluid 16 S rDNA PCR negative samples obtained during second-trimester amniocentesis, extracellular matrix-related protein concentrations (procollagen, osteopontin and IL-33), together with IL-19 and TNFα, were observed higher at this time in cases of later spontaneous preterm birth.
Identifiants
pubmed: 36918342
doi: 10.1111/aogs.14544
pmc: PMC10072248
doi:
Substances chimiques
Tumor Necrosis Factor-alpha
0
Osteopontin
106441-73-0
Interleukin-33
0
Interleukin-6
0
Procollagen
0
Cytokines
0
Transforming Growth Factor beta
0
Banques de données
ClinicalTrials.gov
['NCT00718705']
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
597-604Subventions
Organisme : French Ministry of Public Health
ID : AOM06046
Informations de copyright
© 2023 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).
Références
J Perinat Med. 1999;27(1):26-34
pubmed: 10343931
PLoS One. 2018 Nov 7;13(11):e0206290
pubmed: 30403730
Cold Spring Harb Perspect Med. 2015 Apr 27;5(11):
pubmed: 25918180
J Immunol. 2017 Feb 1;198(3):1345-1356
pubmed: 28031337
N Engl J Med. 2000 May 18;342(20):1500-7
pubmed: 10816189
Hum Reprod. 2007 Apr;22(4):938-44
pubmed: 17204524
J Immunol. 2002 Oct 15;169(8):4288-97
pubmed: 12370360
J Immunol. 2010 Feb 1;184(3):1526-35
pubmed: 20042577
Mol Hum Reprod. 2015 Apr;21(4):369-81
pubmed: 25589517
Exp Cell Res. 2018 Jan 15;362(2):343-348
pubmed: 29196165
Reprod Sci. 2007 Oct;14(7):629-45
pubmed: 18000225
Hum Reprod. 2012 Jul;27(7):2001-9
pubmed: 22587998
Biol Reprod. 2001 Sep;65(3):820-8
pubmed: 11514347
J Perinat Med. 2020 Sep 25;48(7):665-676
pubmed: 32716907
Acta Obstet Gynecol Scand. 2023 May;102(5):597-604
pubmed: 36918342
Immunity. 2009 Jul 17;31(1):84-98
pubmed: 19559631
Clin Rheumatol. 2011 Jun;30(6):825-30
pubmed: 21246230
J Cell Mol Med. 2010 Jun;14(6B):1726-39
pubmed: 19508382
Am J Obstet Gynecol. 2017 Dec;217(6):693.e1-693.e16
pubmed: 28964823
Science. 2014 Aug 15;345(6198):760-5
pubmed: 25124429
Placenta. 2016 Aug;44:1-5
pubmed: 27452431
Obstet Gynecol. 2014 Mar;123(3):506-513
pubmed: 24499752
Mol Hum Reprod. 2017 Oct 1;23(10):708-724
pubmed: 28962035
Nat Rev Immunol. 2010 Feb;10(2):103-10
pubmed: 20081870
Eur J Obstet Gynecol Reprod Biol. 2010 Feb;148(2):147-51
pubmed: 19945777
Hum Reprod Update. 2016 Sep;22(5):535-60
pubmed: 27363410
Eur J Immunol. 2005 May;35(5):1576-82
pubmed: 15827959
Am J Obstet Gynecol. 1999 Nov;181(5 Pt 1):1142-8
pubmed: 10561634
Am J Obstet Gynecol MFM. 2020 May;2(2):100059
pubmed: 33345952
Am J Obstet Gynecol. 2014 Feb;210(2):125.e1-125.e15
pubmed: 24274987
Sci Transl Med. 2018 Apr 25;10(438):
pubmed: 29695455
Am J Reprod Immunol. 2018 Jun;79(6):e12820
pubmed: 29457302
Lancet. 2008 Jan 5;371(9606):75-84
pubmed: 18177778
Biol Reprod. 2002 Mar;66(3):718-25
pubmed: 11870079
J Perinat Med. 2019 Apr 24;47(3):304-310
pubmed: 30730845
Nat Med. 2017 Jan;23(1):128-135
pubmed: 27918564